Purchase Order 75N91018P00560

This $24,011 firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for the acquisition of "NATURAL HISTORY OF FAMILIAL CARCINOID: TUMOR SINGLE CELL ANALYSIS". The contract does not have a set-aside designation and was completed on December 17, 2020. 10X Genomics is a life sciences technology company that specializes in...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $16,875 firm fixed price purchase order to Bionano Genomics, Inc. to deliver NEXUS COPY NUMBER DISCOVERY services for one year. The contract will support the NIH National Human Genome Research Institute's genomic research efforts through Bionano Genomics' single-molecule optical mapping technology, which enables structural variant detection and advanced genome analysis....

The U.S. Food and Drug Administration (FDA) awarded a $15,000 firm fixed price purchase order to 10X Genomics, Inc. for a Parallel Partitioning System Service Agreement on June 22, 2020, with an ultimate completion date of June 27, 2023. The contract was not designated as a set-aside and was performed at 10X Genomics' headquarters location in Pleasanton, California. 10X Genomics is a leading biotechnology company specializing in advanced genomic analysis platforms, including single-cell and...

The National Institute of Neurological Disorders and Stroke awarded a $12,306.50 firm fixed-price BPA call to 10X Genomics, Inc. on April 24, 2023, with an ultimate completion date of June 30, 2023. The contract covers Chromium Next GEM Chip and Chromium Next GEM Single Cell Multinome ATAC products, which are advanced genomic analysis tools used for single-cell and spatial transcriptomics research. This award represents a delivery order under an existing Blanket Purchase Agreement and does not...

The National Institute on Aging awarded a firm fixed-price delivery order valued at $19,301.77 to 10X Genomics, Inc. for in-vitro diagnostic substance manufacturing on September 19, 2025, with an ultimate completion date of October 13, 2025. The order encompasses GEM-X Universal 3' Gene Expression V4 samples (4 units) and Chromium GEM-X Single Cell 3' Chip Kit V4 products (4 chips) to be performed at 10X Genomics' Pleasanton, California facility. This delivery order was issued without a...

This federal contract award is to 10X Genomics, Inc., a biotechnology company based in Pleasanton, California. The award, made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is for the supply of 10X Genomics' single-cell and spatial library prep kits for use in the Weinstein Lab. The contract has a ceiling value of $12,390.20 and a completion date of December 31, 2025. It is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. This...

The U.S. Food and Drug Administration (FDA) awarded a firm fixed-price purchase order to Nexus Group, LLC for preventive maintenance and repair services on an Illumina MiSeq benchtop next-generation sequencer located at the FDA's Silver Spring, Maryland facility. The contract, valued at $10,680 and set to conclude on April 30, 2025, was awarded on June 6, 2024, without a set-aside designation. Under the agreement, Nexus Group will provide one scheduled annual on-site preventive maintenance...

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

10X Genomics, Inc. has been awarded a firm fixed price contract valued at $19,539 by the Department of Health and Human Services' National Institutes of Health National Institute of Dental and Craniofacial Research. The contract calls for delivery of a Xenium Standalone Custom 301 to 480 Gene Panel consisting of 16 reactions to support biomedical research efforts. Performance will take place in Pleasanton, California by March 8, 2024. No set-aside designation was applied to this award...

NUGEN TECHNOLOGIES, INC. received a $7,219.20 firm fixed-price Blanket Purchase Agreement (BPA) call from the National Institute of Environmental Health Sciences on August 16, 2016, with completion targeted for March 31, 2017. The award was issued to Tecan Genomics, Inc., a Switzerland-based manufacturer of life science laboratory automation and detection solutions specializing in genomic research technologies. The work will be performed in San Carlos, California. This contract was not subject...